Table 4.
Multivariable logistic regression results (using GEE) for individual nutrient deficiency and related independent variables for Sleeve Gastrectomy and Gastric Bypass participants.
Dependent Variable | Independent Variablea | Sleeve Gastrectomy | Gastric Bypass | ||||||
---|---|---|---|---|---|---|---|---|---|
Model 1e | Model 2f | Model 1e | Model 2f | ||||||
Odds ratio (95% CI) | p value | Odds ratio (95% CI) | p value | Odds ratio (95% CI) | p value | Odds ratio (95% CI) | p value | ||
Iron deficiency (Ferritin <30 ug/L and Transferrin Saturation <16%)g | Preop | Ref | Ref | Ref | Ref | ||||
1–3 months postop | 1.30 (0.64, 2.64) | 0.5 | 1.49 (0.38, 5.87) | 0.6 | 0.73 (0.44, 1.23) | 0.2 | 0.82 (0.32, 2.11) | 0.7 | |
6 months postop | 1.47 (0.71, 3.07) | 0.3 | 2.05 (0.59, 7.06) | 0.3 | 0.79 (0.39, 1.57) | 0.5 | 1.28 (0.35, 4.70) | 0.7 | |
12 months postop | 1.66 (0.81, 3.40) | 0.2 | 4.11 (1.04, 16.2) | 0.04 | 0.83 (0.36, 1.88) | 0.7 | 1.17 (0.35, 3.97) | 0.8 | |
Oral iron supplement doseb | 1.02 (0.74, 1.40) | 0.9 | 0.75 (0.47, 1.21) | 0.2 | |||||
Female | 3.52 (0.45, 27.4) | 0.2 | 5.37 (1.06, 27.1) | 0.04 | |||||
CRP >5mg/L | 1.90 (1.04, 3.44) | 0.04 | 0.80 (0.32, 2.03) | 0.6 | |||||
Vitamin B12 deficiency and insufficiency (<133 pmol/L) | Preop | Ref | Ref | Ref | |||||
1–3 months postop | 1.08 (0.25, 4.57) | 0.9 | 0.73 (0.11, 4.69) | 0.7 | 0.14 (0.03, 0.62) | 0.01 | |||
6 months postop | 1.75 (0.58, 5.29) | 0.3 | 1.24 (0.26, 5.89) | 0.8 | 0.30 (0.10, 0.94) | 0.04 | |||
12 months postop | 2.07 (0.58, 7.42) | 0.3 | 2.39 (0.46, 12.3) | 0.3 | 0.54 (0.20, 1.44) | 0.2 | |||
Oral vitamin B12 supplement doseb | 1.05 (0.69, 1.60) | 0.8 | |||||||
IM vitamin B12 supplementationc | 1.16 (0.10, 13.9) | 0.9 | |||||||
Metformind | 2.78 (0.94, 8.27) | 0.07 | |||||||
CRP >5mg/L | 1.29 (0.48, 3.43) | 0.6 | |||||||
Folate deficiency (<10 nmol/L) | Preop | Ref | Ref | Ref | Ref | ||||
1–3 months postop | 0.95 (0.20, 4.65) | 1 | 2.91 (0.39, 21.7) | 0.3 | 0.65 (0.08, 5.45) | 0.7 | 0.76 (0.07, 7.94) | 0.8 | |
6 months postop | 3.80 (1.14, 12.7) | 0.03 | 12.9 (2.00, 83.7) | 0.007 | 3.30 (1.07, 10.2) | 0.04 | 8.56 (1.64, 44.6) | 0.01 | |
12 months postop | 1.09 (0.89, 10.7) | 0.08 | 3.68 (0.64, 21.9) | 0.1 | 2.00 (0.28, 14.6) | 0.5 | 7.67 (1.10, 53.7) | 0.04 | |
Oral folic acid supplement doseb | 0.78 (0.62, 0.98) | 0.04 | 0.93 (0.74, 1.17) | 0.5 | |||||
CRP >5mg/L | 1.22 (0.37, 4.00) | 0.7 | 9.46 (2.20, 40.7) | 0.003 | |||||
Vitamin D deficiency and insufficiency (<50 nmol/L) | Preop | Ref | Ref | Ref | Ref | ||||
1–3 months postop | 0.15 (0.06, 0.37) | <0.001 | 0.21 (0.07, 0.66) | 0.008 | 0.62 (0.27, 1.41) | 0.25 | 1.93 (0.64, 5.82) | 0.2 | |
6 months postop | 0.20 (0.09, 0.41) | <0.001 | 0.16 (0.05, 0.56) | 0.004 | 0.57 (0.24, 1.36) | 0.21 | 3.19 (0.88, 11.5) | 0.08 | |
12 months postop | 0.27 (0.14, 0.54) | <0.001 | 0.21 (0.05, 0.82) | 0.02 | 0.80 (0.33, 1.94) | 0.63 | 5.10 (1.24, 20.9) | 0.03 | |
Oral vitamin D supplement doseb | 1.03 (0.88, 1.21) | 0.7 | 0.74 (0.65, 0.85) | <0.001 | |||||
CRP >5mg/L | 1.32 (0.60, 3.00) | 0.5 | 1.83 (0.75, 4.49) | 0.2 | |||||
HbA1c (%) | 0.91 (0.68, 1.22) | 0.5 | 0.96 (0.69, 1.33) | 0.8 | |||||
Vitamin B1 deficiency (<0.9 nmol/g Hb) | Preop | Ref | Ref | Ref | Ref | ||||
1–3 months postop | 0.64 (0.27, 1.48) | 0.3 | 1.87 (0.69, 5.07) | 0.2 | 0.25 (0.10, 0.63) | 0.003 | 8.27 (2.67, 25.6) | <0.001 | |
6 months postop | 1.00 (0.41, 2.41) | 1 | 1.52 (0.42, 5.59) | 0.5 | 0.52 (0.18, 1.49) | 0.2 | 6.27 (1.86, 21.1) | 0.003 | |
12 months postop | 6.60 (1.18, 36.9) | 0.03 | 0.24 (0.05, 1.22) | 0.09 | 1.54 (0.30, 8.27) | 0.6 | 2.04 (0.30, 13.9) | 0.5 | |
Oral vitamin B1 supplement doseb | 0.49 (0.27, 0.88) | 0.02 | 0.45 (0.29, 0.70) | <0.001 | |||||
CRP >10mg/L | 0.17 (0.05, 0.59) | 0.005 | 1.78 (0.73, 4.36) | 0.2 | |||||
Vitamin A deficiency (<1.1 umol/L) | Preop | Ref | Ref | ||||||
1–3 months postop | 6.31 (2.02, 19.8) | 0.002 | 5.25 (0.93, 29.5) | 0.06 | |||||
6 months postop | 3.56 (1.24, 10.2) | 0.02 | 2.99 (0.53, 16.8) | 0.2 | |||||
12 months postop | 0.78 (0.12, 5.02) | 0.8 | 0.79 (0.10, 6.43) | 0.8 | |||||
Oral vitamin A supplement doseb | 1.11 (0.91, 1.37) | 0.3 | |||||||
CRP >10mg/L | 3.25 (1.04, 10.2) | 0.04 | |||||||
Plasma Glutathione Peroxidase deficiency (<370 U/L) | Preop | Ref | Ref | ||||||
1–3 months postop | 2.38 (1.35, 4.18) | 0.003 | 1.74 (0.64, 4.79) | 0.3 | |||||
6 months postop | 1.83 (1.03, 3.24) | 0.04 | 1.43 (0.40, 5.08) | 0.6 | |||||
12 months postop | 0.54 (0.28, 1.03) | 0.06 | 0.38 (0.11, 1.32) | 0.1 | |||||
Oral selenium supplement doseb | 0.92 (0.75, 1.13) | 0.4 | |||||||
CRP >5mg/L | 2.27 (1.16, 4.44) | 0.02 | |||||||
Hba1c (%) | 0.51 (0.37, 0.71) | <0.001 | |||||||
Red Cell Glutathione Peroxidase deficiency (<25 U/g Hb) | Preop | Ref | Ref | ||||||
1–3 months postop | 1.01 (0.50, 2.01) | 1 | 1.09 (0.25, 4.66) | 0.9 | |||||
6 months postop | 1.14 (0.43, 3.04) | 0.8 | 1.13 (0.15, 8.80) | 0.9 | |||||
12 months postop | 2.07 (0.79, 5.38) | 0.1 | 2.27 (0.30, 17.3) | 0.4 | |||||
Oral selenium supplement doseb | 1.14 (0.85, 1.53) | 0.4 | |||||||
CRP >5mg/L | 1.73 (0.33, 9.14) | 0.5 | |||||||
HbA1c (%) | 1.20 (0.89, 1.64) | 0.2 |
ref reference category.
aUsing the Generalised Estimated Equation, comparing the indpendent variables to preoperative nutrient deficiency prevalence as the reference category.
bOral supplementation dose is loge(supplementation dose/day +1) as is not normally distributed and contains zero values.
cPatient received any dose of IM vitamin B12 supplementation prior to their blood test at that timepoint.
dOn any dose of metformin at time of blood test.
eModel 1: multivariable model with only time as the independent variable.
fModel 2: multivariable model with time, supplementation, inflammation (measured using C-reactive protein (CRP) cut offs to define inflammation) and metformin for vitamin B12 as independent variables.
gCases that used IV iron excluded from analysis.